APS-Arzneimittel-Parallelimport- Service AG
APS-Arzneimittel-Parallelimport- Service AG is a Generics company in Switzerland recorded by Swissmedic as the authorisation holder for 39 human medicines. That places it 38 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Generics |
|---|---|
| City | Not available |
| Canton | Not available |
| Authorisation holder | Yes |
| Medicines | 39 |
| Founded | Not available |
| Employees | 1-10 |
| Parent group | Not available |
| Activity | Not available |
| Website | aps-schweiz.ch |
Medicines authorised in Switzerland
APS-Arzneimittel-Parallelimport- Service AG is recorded by Swissmedic as the authorisation holder for 39 human medicines. The table shows 39 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
39 of 39 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Arimidex 1 mg | 68805 | B | L02BG03 | 2022-07-22 |
| Arimidex 1 mg | 68806 | B | L02BG03 | 2022-07-22 |
| Arimidex 1 mg | 68807 | B | L02BG03 | 2022-07-22 |
| Baraclude 0.5 mg | 68837 | A | J05AF10 | 2022-08-29 |
| Baraclude 0.5 mg | 68838 | A | J05AF10 | 2022-08-29 |
| Baraclude 0.5 mg | 68839 | A | J05AF10 | 2022-08-29 |
| Buscopan | 56802 | D | A03BB01 | 2007-10-18 |
| Cellcept 250 mg | 67387 | B | L04AA06 | 2019-10-02 |
| Cellcept 250 mg | 67389 | B | L04AA06 | 2019-10-02 |
| Cellcept 250 mg | 67391 | B | L04AA06 | 2019-10-02 |
| Cellcept 250 mg | 67393 | B | L04AA06 | 2019-10-02 |
| Cellcept 500 mg | 67388 | B | L04AA06 | 2019-10-02 |
| Cellcept 500 mg | 67390 | B | L04AA06 | 2019-10-02 |
| Cellcept 500 mg | 67392 | B | L04AA06 | 2019-10-02 |
| Cellcept 500 mg | 67394 | B | L04AA06 | 2019-10-02 |
| Cerazette | 67300 | B | G03AC09 | 2019-06-20 |
| Cerazette 0.075 mg | 67385 | B | G03AC09 | 2019-09-25 |
| Cerazette 0.075 mg | 67386 | B | G03AC09 | 2019-09-25 |
| FEMARA 2.5 mg | 67301 | B | L02BG04 | 2019-07-02 |
| FEMARA 2.5 mg | 67302 | B | L02BG04 | 2019-07-02 |
| FEMARA 2.5 mg | 67303 | B | L02BG04 | 2019-07-02 |
| FEMARA 2.5 mg | 68589 | B | L02BG04 | 2022-01-25 |
| Kivexa 600 mg / 300 mg | 68251 | A | J05AR02 | 2021-09-16 |
| Kivexa 600 mg / 300 mg | 68253 | A | J05AR02 | 2021-09-16 |
| Kivexa 600mg/300 mg | 68455 | A | J05AR02 | 2021-09-16 |
| Norit | 44812 | D | A07BA01 | 1987-06-02 |
| Nuvaring | 69704 | B | G02BB01 | 2024-08-29 |
| Nuvaring | 69705 | B | G02BB01 | 2024-08-29 |
| Nuvaring | 69706 | B | G02BB01 | 2024-08-29 |
| Prograf 0 | 68943 | A | L04AD02 | 2022-11-17 |
| Prograf 0.5 mg | 66783 | A | L04AD02 | 2018-06-11 |
| Remicade 100 mg | 68736 | A | L04AB02 | 2022-06-16 |
| Remicade 100 mg | 68738 | A | L04AB02 | 2022-06-16 |
| Remicade 100 mg | 68739 | A | L04AB02 | 2022-06-16 |
| Remsima 100 mg | 68734 | A | L04AB02 | 2022-06-16 |
| Remsima 100 mg | 68735 | A | L04AB02 | 2022-06-16 |
| Remsima 100 mg | 68737 | A | L04AB02 | 2022-06-16 |
| Visanne 2.0 mg | 68831 | B | G03DB08 | 2022-09-12 |
| Visanne 2.0 mg | 68832 | B | G03DB08 | 2022-09-12 |
Frequently asked questions
How many medicines does APS-Arzneimittel-Parallelimport- Service AG have authorised in Switzerland?
APS-Arzneimittel-Parallelimport- Service AG is recorded by Swissmedic as the authorisation holder for 39 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is APS-Arzneimittel-Parallelimport- Service AG based?
We have no confirmed Swiss address for APS-Arzneimittel-Parallelimport- Service AG. We add it as soon as the commercial register or the company confirms it.
Is APS-Arzneimittel-Parallelimport- Service AG a Swissmedic authorisation holder?
Yes. APS-Arzneimittel-Parallelimport- Service AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.